Primary packaging design needs to consider the needs of all patients.

When pushing for more patient-centric drug development, modified release formulations must be considered.

Experts explain how their companies have coped throughout the pandemic.

We reveal The Medicine Maker 2021 Power List!

AAM calls for policies in the US that encourage greater use of biosimilars.

Why multilayer tablets, multiparticulates, and mini tablets could lead the way in patient-centric drug delivery.

Schott explains how ready-to-use containers can improve total costs of ownership for pharma companies.

Why organ-on-chip technology could transform drug discovery and development.

How can pharma use synthetic data to enhance clinical trials?

Is there a place for traditional medicines in the pharmaceutical industry?